Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma

Journal of Experimental Medicine

Volumn 203, Issue 2, 2006, Pages 311-317

  Pasqualucci, Laura ^a   Compagno, Mara ^a   Houldsworth, Jane ^b   Monti, Stefano ^c   Grunn, Adina ^a   Nandula, Subhadra V ^a   Aster, Jon C ^d   Murty, Vundavally V ^a   Shipp, Margaret A ^e   Dalla Favera, Riccardo ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; B CELL LYMPHOMA; CARCINOGENESIS; EPIGENETICS; FRAMESHIFT MUTATION; GENE DELETION; GENE INACTIVATION; GENE MUTATION; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RNA SPLICING; TUMOR SUPPRESSOR GENE;

B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINE, TUMOR; CODON, NONSENSE; FRAMESHIFT MUTATION; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; PLASMA CELLS; REPRESSOR PROTEINS; RNA SPLICE SITES; TRANSCRIPTION FACTORS;

EID: 33344454909     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20052204     Document Type: Article

References (27)

1. Abramson, J.S., and M.A. Shipp. 2005. Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach. Blood. 106:1164-1174.
2. Alizadeh, A.A., M.B. Eisen, R.E. Davis, C. Ma, I.S. Lossos, A. Rosenwald, J.C. Boldrick, H. Sabet, T. Tran, X. Yu, et al. 2000. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 403:503-511.
3. Shaffer, A.L., A. Rosenwald, and L.M. Staudt. 2002. Lymphoid malignancies: the dark side of B-cell differentiation. Nat. Rev. Immunol. 2:920-932.
4. Rosenwald, A., G. Wright, K. Leroy, X. Yu, P. Gaulard, R.D. Gascoyne, W.C. Chan, T. Zhao, C. Haioun, T.C. Greiner, et al. 2003. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J. Exp. Med. 198:851-862.
5. Savage, K.J., S. Monti, J.L. Kutok, G. Cattoretti, D. Neuberg, L. De Leval, P. Kurtin, P. Dal Cin, C. Ladd, F. Feuerhake, et al. 2003. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood. 102:3871-3879.
6. Wright, G., B. Tan, A. Rosenwald, E.H. Hurt, A. Wiestner, and L.M. Staudt. 2003. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc. Natl. Acad. Sci. USA. 100:9991-9996.
7. Monti, S., K.J. Savage, J.L. Kutok, F. Feuerhake, P. Kurtin, M. Mihm, B. Wu, L. Pasqualucci, D. Neuberg, R.C. Aguiar, et al. 2005. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood. 105:1851-1861.
8. Bea, S., A. Zettl, G. Wright, I. Salaverria, P. Jehn, V. Moreno, C. Burek, G. Ott, X. Puig, L. Yang, et al. 2005. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. Blood. 106:3183-3190.
9. Dalla-Favera, R., and L. Pasqualucci. 2003. Molecular Genetics of Lymphoma. In Non-Hodgkin's lymphomas. P.M. Mauch, J.O. Armitage, B. Coiffier, R. Dalla-Favera, N.L. Harris, editors. Lippincott Williams & Wilkins, Philadelphia. 825-843.
10. Offit, K., S.C. Jhanwar, M. Ladanyi, D.A. Filippa, and R.S. Chaganti. 1991. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment. Genes Chromosomes Cancer. 3:189-201.
11. Pasqualucci, L., P. Neumeister, T. Goossens, G. Nanjangud, R.S. Chaganti, R. Kuppers, and R. Dalla-Favera. 2001. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature. 412:341-346.
12. Rao, P.H., J. Houldsworth, K. Dyomina, N.Z. Parsa, J.C. Cigudosa, D.C. Louie, L. Popplewell, K. Offit, S.C. Jhanwar, and R.S. Chaganti. 1998. Chromosomal and gene amplification in diffuse large B-cell lymphoma. Blood. 92:234-240.
13. Gaidano, G., R.S. Hauptschein, N.Z. Parsa, K. Offit, P.H. Rao, G. Lenoir, D.M. Knowles, R.S. Chaganti, and R. Dalla-Favera. 1992. Deletions involving two distinct regions of 6q in B-cell non-Hodgkin lymphoma. Blood. 80:1781-1787.
14. Offit, K., N.Z. Parsa, G. Gaidano, D.A. Filippa, D. Louie, D. Pan, S.C. Jhanwar, R. Dalla-Favera, and R.S. Chaganti. 1993. 6q deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphoma. Blood. 82:2157-2162.
15. Turner, C.A., Jr., D.H. Mack, and M.M. Davis. 1994. Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell. 77:297-306.
16. Angelin-Duclos, C., G. Cattoretti, K.I. Lin, and K. Calame. 2000. Commitment of B lymphocytes to a plasma cell fate is associated with Blimp-1 expression in vivo. J. Immunol. 165:5462-5471.
17. Cattoretti, G., C. Angelin-Duclos, R. Shaknovich, H. Zhou, D. Wang, and B. Alobeid. 2005. PRDM1/Blimp-1 is expressed in human B-lymphocytes committed to the plasma cell lineage. J. Pathol. 206:76-86.
18. Shaffer, A.L., K.I. Lin, T.C. Kuo, X. Yu, E.M. Hurt, A. Rosenwald, J.M. Giltnane, L. Yang, H. Zhao, K. Calame, and L.M. Staudt. 2002. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity. 17:51-62.
19. Shapiro-Shelef, M., K.I. Lin, L.J. McHeyzer-Williams, J. Liao, M.G. McHeyzer-Williams, and K. Calame. 2003. Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells. Immunity. 19:607-620.
20. Gyory, I., G. Fejer, N. Ghosh, E. Seto, and K.L. Wright. 2003. Identification of a functionally impaired positive regulatory domain I binding factor 1 transcription repressor in myeloma cell lines. J. Immunol. 170:3125-3133.
21. Yu, J., C. Angelin-Duclos, J. Greenwood, J. Liao, and K. Calame. 2000. Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase. Mol. Cell. Biol. 20:2592-2603.
22. Keller, A.D., and T. Maniatis. 1992. Only two of the five zinc fingers of the eukaryotic transcriptional repressor PRDI-BF1 are required for sequence-specific DNA binding. Mol. Cell. Biol. 12:1940-1949.
23. Fearon, E. 2002. Tumor-Suppressor Genes. In The Genetic Bases of Human Cancer. K.K.W. Vogelstein, editor. McGraw Hill, New York. 197-206.
24. Hans, C.P., D.D. Weisenburger, T.C. Greiner, R.D. Gascoyne, J. Delabie, G. Ott, H.K. Muller-Hermelink, E. Campo, R.M. Braziel, E.S. Jaffe, et al. 2004. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 103:275-282.
25. Lin, Y., K. Wong, and K. Calame. 1997. Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation. Science. 276:596-599.
26. Messika, E.J., P.S. Lu, Y.J. Sung, T. Yao, J.T. Chi, Y.H. Chien, and M.M. Davis. 1998. Differential effect of B lymphocyte-induced maturation protein (Blimp-1) expression on cell fate during B cell development. J. Exp. Med. 188:515-525.
27. Shaffer, A.L., X. Yu, Y. He, J. Boldrick, E.P. Chan, and L.M. Staudt. 2000. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity. 13:199-212.